Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis

PURPOSE: To compare the efficacy and safety of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2%, and Bepotastine besilate 1.5% ophthalmic solutions in the treatment of allergic conjunctivitis. METHODS: This is a prospective, observer-masked, comparative study of 180 patients with mild to moderate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayyappanavar, Shruti, Sridhar, Sriya, Kumar, Kiran, Jayanthi, C R, Gangasagara, Suresh Babu, Rathod, B L Sujatha, Preethi, B, Mittal, Preeti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933849/
https://www.ncbi.nlm.nih.gov/pubmed/33463568
http://dx.doi.org/10.4103/ijo.IJO_2083_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933849/
https://www.ncbi.nlm.nih.gov/pubmed/33463568
http://dx.doi.org/10.4103/ijo.IJO_2083_20

Ejemplares similares